Twenty-five years of translational medicine in antiretroviral therapy: promises to keep. - Test2 - elhamkhani - TriplyDB

Twenty-five years of translational medicine in antiretroviral therapy: promises to keep.

Twenty-five years of translational medicine in antiretroviral therapy: promises to keep.

http://www.wikidata.org/entity/Q37770831

about

From modules to medicine: How modular domains and their associated networks can enable personalized medicine Microbicides: topical prevention against HIV Targeting γδ T cells for immunotherapy of HIV disease Respiratory infection and the impact of pulmonary immunity on lung health and disease Human Immunodeficiency Virus (HIV).Using combination therapy to thwart drug resistance.Multivalent agents containing 1-substituted 2,3,4-trihydroxyphenyl moieties as novel synthetic polyphenols directed against HIV-1.[Human immunodeficiency virus: position of Blood Working Group of the Federal Ministry of Health].A mechanistic theory to explain the efficacy of antiretroviral therapy.Curing consortium fatigue.Translational Research: From Biological Discovery to Public Benefit (or Not)

P2860

Q26830811-8A61C8E5-63A2-47F3-9586-D2BC6CCBFD9B Q26999403-A7C1DC09-0341-401E-8844-63F056FD2AEA Q34585223-1FBD96A5-D92A-4739-9E9F-D68232E53F2A Q36488767-79854FD6-6A41-44BE-A12A-B85C6AA3B605 Q37045832-588BCE07-0D5A-41F8-959C-C9E38F86CC03 Q38644503-16958F58-07A1-4EE2-AA43-FDBC7437939A Q38985176-8F2C2C49-E268-4E7B-87F5-F9CBC664CA02 Q40942917-50219CE4-2864-4EE5-A9BA-A5E07526BEA8 Q43721565-267CA67C-6964-4620-BAC9-8B4A9907EB4D Q44603746-525587CC-6437-4069-A73B-130045FA7B91 Q59042590-E9CDA8A6-BAE3-480F-96D0-90E647E28998

P2860

Twenty-five years of translational medicine in antiretroviral therapy: promises to keep.

http://www.wikidata.org/entity/Q37770831

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on July 2010

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Twenty-five years of translational medicine in antiretroviral therapy: promises to keep.

@en

Twenty-five years of translational medicine in antiretroviral therapy: promises to keep.

@nl

type

label

Twenty-five years of translational medicine in antiretroviral therapy: promises to keep.

@en

Twenty-five years of translational medicine in antiretroviral therapy: promises to keep.

@nl

prefLabel

Twenty-five years of translational medicine in antiretroviral therapy: promises to keep.

@en

Twenty-five years of translational medicine in antiretroviral therapy: promises to keep.

@nl

P1433

Q37770831-27F948EE-2F6F-4CD1-AB2B-A9D5F80B4523

P1476

Q37770831-99AD7A8E-635D-4358-A432-9B662FD26337

P2093

Q37770831-199FE5ED-FE93-4D4F-902F-8E17EFE1BC44

P2860

Q37770831-125A52D9-67FD-412C-8B9B-AD04822E69A1

Q37770831-1353E86E-A380-4B3F-B96E-81984C06CE63

Q37770831-14803E0E-F781-4609-9133-C933962D97D7

Q37770831-14D21538-74A2-4C34-A393-DA9526179C57

Q37770831-224A69BC-2FBE-44D9-9D64-6060254A3CAB

Q37770831-48A15B45-7ABB-4757-976F-D559C04FE322

Q37770831-5B257AB1-029D-4BAB-BF21-2C459A2F3B36

Q37770831-62B73344-6958-4F60-A0AF-5EDEA44D9D40

Q37770831-73C57589-2484-49AF-AC77-BBD64776C60A

Q37770831-7C62EE4F-DFAC-432D-89B5-E3093BE6C0F2

P304

Q37770831-C5C192E5-B0C6-4C0D-85CD-FA2766B17BD3

P31

Q37770831-FD6E9DD0-1DAA-4488-A1E8-954A06797BFE

P356

Q37770831-6A5CCD92-B3E3-4683-A6E1-ABA3D59683D0

P407

Q37770831-129A4C1A-CC1C-4A12-9CC3-0FE116B46611

P433

Q37770831-9EC6ADE6-02AC-4A90-B951-0A8C16CFD2A1

P478

Q37770831-13AC4D7A-1E3A-4F27-BCF8-1FD496E6C1EF

P577

Q37770831-FF370AC6-8FAC-4741-A1BF-BE6C21CE4434

P5875

Q37770831-F7258330-1197-4153-951B-D84C163A4DB5

P698

Q37770831-E3F16249-41EC-413C-BC32-15D308E6E88E

P921

Q37770831-58355A62-80DC-4B26-81AA-42820EA09306

P356

SCITRANSLMED.3000749

P1433

Science Translational Medicine

P1476

Twenty-five years of translational medicine in antiretroviral therapy: promises to keep.

@en

P2093

Samuel Broder

http://www.w3.org/2001/XMLSchema#string

P2860

A reflection on HIV/AIDS research after 25 years

A new human immunodeficiency virus derived from gorillas

3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro

Phosphorylation of 3'-azido-3'-deoxythymidine and selective interaction of the 5'-triphosphate with human immunodeficiency virus reverse transcriptase

Active human immunodeficiency virus protease is required for viral infectivity

The development of antiretroviral therapy and its impact on the HIV-1/AIDS pandemic

Novel targets for HIV therapy

Inhibition of human immunodeficiency virus (HIV-1/HTLV-IIIBa-L) replication in fresh and cultured human peripheral blood monocytes/macrophages by azidothymidine and related 2',3'-dideoxynucleosides

Inhibition of the in vitro infectivity and cytopathic effect of human T-lymphotrophic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV) by 2',3'-dideoxynucleosides

Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry

P304

39ps33

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1126/SCITRANSLMED.3000749

http://www.w3.org/2001/XMLSchema#string

P407

P433

39

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P577

2010-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

45101740

http://www.w3.org/2001/XMLSchema#string

P698

20610849

http://www.w3.org/2001/XMLSchema#string

P921

antiretroviral drug